TOP NEWS: GSK hails Menveo vaccine approval in one-vial presentation
(Alliance News) - GSK PLC on Monday said the meningitis vaccine Menveo has been approved by the US Food & Drug Administration in a single-vial presentation to help prevent disease caused by meningococcal bacteria serogroups A, C, Y, and W. Read More